Regulation of plasminogen activator inhibitor (PAI)-1 expression in a human trophoblast cell line by glucocorticoid (GC) and transforming growth factor (TGF)-β

Placenta

Volumn 23, Issue 10, 2002, Pages 727-734

  Ma, Y ^a   Ryu, J S ^a   Dulay, A ^a   Segal, M ^a   Guller, S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; ESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROGESTERONE; TESTOSTERONE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CELL ASSAY; CELL CULTURE; CELL FUNCTION; CELL LINE; CONTROLLED STUDY; CYTOTROPHOBLAST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; NORTHERN BLOTTING; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TROPHOBLAST; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PREGNANCY; PROMOTER REGION;

BLOTTING, NORTHERN; DEXAMETHASONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREGNANCY; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLASTS;

EID: 0036834573     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(02)90863-5     Document Type: Article

References (62)

1. Abe M, Harpel JG, Metz CN, Nunes I, Loskutoff DJ & Rifkin DB (1994) An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem, 216, 276-284.
2. Ando N, Hirahara F, Fukushima J, Kawamoto S, Okuda K, Funabashi T, Gorai I & Minaguchi H (1998) Differential gene expression of TGF-β isoforms and TGF-β receptors during the first trimester of pregnancy at the human maternal-fetal interface. Am J Reprod Immunol, 40, 48-56.
3. Bruzdzinski CJ, Johnson MR, Goble CA, Winograd SS & Gelehrter TD (1993) Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements. Mol Endocrinol, 7, 1169-1177.
4. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M & Lye SJ (1999) Inhibition of TGF-β3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest, 103, 1641-1650.
5. Caniggia I, Winter J, Lye SJ & Post M (2000) Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta, 21(Suppl A), S25-30.
6. Declerck PJ, De Mol M, Alessi MC, Baudner S, Paques EP, Preissner KT, Muller-Berghaus G & Collen D (1988) Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem, 263, 15454-15461.
7. Dickinson JL, Bates EJ, Ferrante A & Antalis TM (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor-α-induced apoptosis. Evidence for an alternative biological function. J Biol Chem, 270, 27894-2904.
8. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Husby H & Berg K (1997) Plasma concentrations of Lp(a) lipoprotein and TGF-β1 are altered in preeclampsia. Clin Genet, 52, 371-376.
9. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espna F, Loskutoff DJ & Schleef RR (1994) Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood, 84, 143-150.
10. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Espana F, Aznar J & Loskutoff DJ (1998) Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost, 79, 500-508.
11. Feinberg RF, Kao LC, Haimowitz JE, Queenan JT Jr, Wun TC, Strauss JF III & Kliman HJ (1989) Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts. Lab Invest, 61, 20-26.
12. Fitzpatrick TE & Graham CH (1998) Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen. Exp Cell Res, 245, 155-162.
13. Graham CH & Lala PK (1991) Mechanism of control of trophoblast invasion in situ. J Cell Physiol, 148, 228-234.
14. Graham CH, Lysiak JJ, McCrae KR & Lala PK (1992) Localization of transforming growth factor-β at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod, 46, 561-572.
15. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N & Lala PK (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res, 206, 204-211.
16. Graham CH (1997) Effect of transforming growth factor-β on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta, 18, 137-143.
17. Grancha S, Estelles A, Gilabert J, Chirivella M, Espana F & Aznar J (1996) Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation. Thromb Haemost, 76, 761-767.
18. Guller S, Wozniak R, Krikun G, Burnham JM, Kaplan P & Lockwood CJ (1993a) Glucocorticoid suppression of human placental fibronectin expression: implications in uterine-placental adherence. Endocrinology, 133, 1139-1146.
19. Guller S, Lacroix N, Krikun G, Wozniak R, Markiewicz L, Wang E-Y, Kaplan P & Lockwood CJ (1993b) Steroid regulation of oncofetal fibronectin expression in human cytotrophoblasts. J Steroid Biochem Molec Biol, 46, 1-10.
20. Guller S, Markiewicz L, Wozniak R, Burnham JM, Wang E-Y, Kaplan P & Lockwood CJ (1994) Developmental regulation of glucocorticoid-mediated effects on extracellular matrix protein expression in the human placenta. Endocrinology, 134, 2064-2071.
21. Guller S, Wozniak R, Kong L & Lockwood CJ (1995) Opposing actions of transforming growth factor-β and glucocorticoids in the regulation of fibronectin expression in the human placenta. J Clin Endocrinol Metab, 80, 3273-3278.
22. Halleux CM, Declerck PJ, Tran SL, Detry R & Brichard SM (1999) Hormonal control of plasminogen activator-1 gene expression in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab, 84, 4097-4105.
23. Hamilton JA, Cheung D, Filonzi EL, Piccoli DS, Wojta J, Gallichio M, McGrath K & Last K (1992) Independent regulation of plasminogen activator inhibitor 2 and plasminogen activator 1 in human synovial fibroblasts. Arthritis Rheum, 35, 1526-1534.
24. Hamilton JA, Whitty GA, Wojita J, Gallichio M, McGrath K & Ianches G (1993) Regulation of plasminogen activator inhibitor-1 levels in human monocytes. Cell Immunol, 152, 7-17.
25. Heaton JH & Gelehrter (1989) Glucocorticoid induction of plasminogen activator inhibitor messenger RNA in rat hepatoma cells. Mol Endocrinol, 3, 349-355.
26. Heckmann M, Wudy SA, Haack D & Pohlandt F (1999) Reference range for serum cortisol in well preterm infants. Arch Dis Child Fetal Neonatal Ed, 81, F171-F174.
27. Heldin C-H, Miyazono K & ten Dijke P (1997) TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465-471.
28. Hofmann GE, Glatstein I, Schatz F, Heller D & Deligdisch L (1994) Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites. Am J Obstet Gynecol, 170, 671-676.
29. Irving JA, Lysiak JJ, Graham CH, Hearn S, Han VK & Lala PK (1995) Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta, 16, 413-433.
30. Jones SA, Brooks AN & Challis JRG (1989) Steroids modulate corticotropin-releasing hormone production in human fetal membranes and placenta. J Clin Endocrinol Metab, 68, 825-830.
31. Kingdom JC & Kaufmann P (1999) Oxygen and placental vascular development. Adv Exp Med Biol, 474, 259-275.
32. Kliman HJ, Nestler JE, Sermasi E, Sanger JM & Strauss JF III (1986) Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae. Endocrinology, 118, 1567-1582.
33. Krikun G, Schatz F, Mackman N, Guller S, Demopoulos R & Lockwood CJ (2000) Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3. Mol Endocrinol, 14, 393-400.
34. Lala PK & Graham CG (2001) TGF-β-responsive human trophoblast-derived cell lines. Placenta, 22, 889-890.
35. Loskutoff DJ, Sawdey M, Keeton M & Schneiderman J (1993) Regulation of PAI-1 gene expression in vivo. Thromb Haemost, 70, 135-137.
36. Ma Y, Lockwood CJ, Bunim AL, Giussani DA, Nathanielsz PW & Guller S (2000) Cell-type specific regulation of fetal fibronectin (FFN) expression in amnion: conservation of glucocorticoid responsiveness in human and non-human primates. Biol Reprod, 62, 1812-1817.
37. Miller DA, Lee A, Matsui Y, Chen EY, Moses HL & Derynck R (1989) Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF-β3) precursor and the comparative expression of TGF β3 and TGF β1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol, 3, 1926-1934.
38. Mitchell EJ & O'Connor-McCourt MD (1991) A transforming growth factor beta (TGF-β) receptor from human placenta exhibits a greater affinity for TGF-β2 than for TGF-β1. Biochemistry, 30, 4350-4356.
39. Mitchell EJ, Fitz-Gibbon L & O'Connor-McCourt MD (1992) Subtypes of betaglycan and of type I and type II transforming growth factor-beta (TGF-β) receptors with different affinities for TGF-β1 and TGF-β2 are exhibited by human placental trophoblast cells. J Cell Physiol, 150, 334-343.
40. Pannekoek H, Veerman H, Lambers H, Diergaarde P, Verweij CL, van Zonneveld AJ & van Mourik JA (1986) Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J, 5, 2539-2544.
41. Parker CR Jr, Buchina ES & Barefoot TK (1994) Abnormal adrenal steroidogenesis in growth-retarded newborn infants. Pediatr Res, 35, 633-636.
42. Pollanen J, Vaheri A, Tapiovaara H, Riley E, Bertram K, Woodrow G & Stevens RW (1990) Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Proc Natl Acad Sci (USA), 87, 2230-2234.
43. Ringer GE, Kallen CB & Strauss III JF (1989) Regulation of human trophoblast function by glucocorticoids: dexamethasone promotes increased secretion of chorionic gonadotropin. Endocrinology, 124, 1625-1631.
44. Robbie LA, Booth NA, Brown AJ & Bennett B (1996) Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler Thromb Vasc Biol, 16, 539-545.
45. Saksela O & Rifkin DB (1988) Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol, 4, 93-126.
46. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS & Vintzileos AM (1995) Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol, 173, 1049-1057.
47. Salafia CM, Pezzullo JC, Minior VK & Divon MY (1997) Placental pathology of absent and reversed end-diastolic flow in growth-restricted fetuses. Obstet Gynecol, 90, 830-836.
48. Sawdy MA & Loskutoff DJ (1991) Regulation of murine plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-β, and transforming growth factor-β. J Clin Invest, 88, 1346-1353.
49. Schatz F & Lockwood CJ (1993) Progestin regulation of plasminogen activator inhibitor type 1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab, 77, 621-625.
50. Seckl JR (1997) Glucocorticoids, feto-placental 11β-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids, 62, 89-94.
51. Shaarawy M, El Meleigy M & Rasheed K (2001) Maternal serum transforming growth factor-β2 in preeclampsia and eclampsia, a potential biomarker of disease severity and fetal outcome. J Soc Gynecol Investig, 8, 27-31.
52. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M & Stewart PM (1998) 11β-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod, 13, 799-804.
53. Sheppard BL & Bonnar J (1999) Uteroplacental hemostasis in intrauterine fetal growth retardation. Semin Thromb Hemost, 25, 443-446.
54. Simpson H, Robson SC, Bulmer JN, Barber A & Lyall F (2002) Transforming growth factor β expression in human placenta and placental bed during early pregnancy. Placenta, 23, 44-58.
55. Song CZ, Siok TE & Gelehrter TD (1998) Smad4/DPC4 and Smad3 mediate transforming growth factor-β (TGF-β) signaling through direct binding to a novel TGF-β responsive element in the human plasminogen activator inhibitor-1 promoter. J Biol Chem, 273, 29287-29290.
56. Song CZ, Tian X & Gelehrter TD (1999) Glucocorticoid receptor inhibits transforming growth factor-β signaling by directly targeting the transcriptional activation function of Smad3. Proc Natl Acad Sci (USA), 96, 11776-11781.
57. Sprengers ED & Kluft C (1987) Plasminogen activator inhibitors. Blood, 69, 381-387.
58. van Zonneveld A-T, Curriden SA & Loskutoff DJ (1988) Type I plasminogen activator inhibitor gene: functional analysis and glucocorticoid regulation of its promoter. Proc Natl Acad Sci (USA), 85, 5525-5529.
59. Vassalli JD, Sappino AP & Belin D (1991) The plasminogen activator/plasmin system. J Clin Invest, 88, 1067-1072.
60. Xu G, Chakraborty C & Lala PK (2001) Expression of TGF-β signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biophys Res Commun, 287, 47-55.
61. Yoon DY, Ma Y, Krikun G, Lockwood CJ, LaChapelle L & Guller S (1998) Glucocorticoid effects in the human placenta: evidence that dexamethasone-mediated inhibition of fibronectin expression in cytotrophoblasts involves a protein intermediate. J Clin Endocrinol Metab, 83, 632-637.
62. Zhou Y, Genbacev O, Damsky CH & Fisher SJ (1998) Oxygen regulates human cytotrophoblast differentiation and invasion: implications for endovascular invasion in normal pregnancy and in pre-eclampsia. J Reprod Immunol, 39, 197-213.